Dr. Joseph “Jeff” Thomis PhD

Joseph “Jeff” Thomis

Dr. Joseph “Jeff” Thomis PhD | Director

Dr. Thomis was appointed to the Board of Directors in January 2017.  He brings more than 40 years of experience in drug discovery, clinical development and commercialization. After a short period in academia, Dr. Thomis played a major role in the development and registration of eight commercially successful cardiovascular and infectious disease products while at Bristol-Myers Squibb. He has also held senior clinical development roles at Quintiles, a global provider of pharmaceutical services, where he was instrumental in the growth of clinical research in Europe. He also specialized in designing and implementing effective regional and global clinical strategies as well as repositioning and restructuring organizations.  Dr. Thomis is currently non-executive director at NovaQuest LLC, a private equity company and chairman of the board of Quotient Clinical, a translational pharmaceutics company. He previously served on the EMEA and American management boards of Quintiles as well as on the board of PDP Courier Services and Idis Group Holdings.